Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 01/12/2018.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Research Papers:
Nuclear receptor REV-ERBα attenuates lipopolysaccharide-induced acute lung injury and inflammation through TLR4 inhibition
Dapeng Yu1,2,*, Yong Li2,*, Yu Zhou3,4,*, Masanobu Abe5, Liang Zong4,6 and Ju Gao1,2
1 Graduate School of Medicine, The Second Xiangya Hospital of Central South University, Changsha, China
2 Department of Anesthesiology, Clinical Medical School of Yangzhou University (Subei People’s Hospital of Jiangsu Province), Yangzhou, Jiangsu, China
3 Department of General Surgery, Suzhou Municipal Hospital (North Campus), Suzhou, Jiangsu, China
4 Department of Gastrointestinal Surgery, Clinical Medical College of Yangzhou University(the Northern Jiangsu People’s Hospital), Yangzhou, Jiangsu, China
5 Division for Health Service Promotion, University of Tokyo, Tokyo, Japan
6 Department of Gastrointestinal Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
* These authors contributed equally to this work
Correspondence to:
Liang Zong, email: [email protected]
Ju Gao, email: [email protected]
Keywords: : rev-erbα; lipopolysaccharide; acute lung injury; nuclear factor-kappa B; toll-like receptor 4
Received: April 04, 2017 Accepted: December 05, 2017 Epub: January 12, 2018
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24207